News

Fierce Biotech6h
Industry ‘deeply disappointed’ as FDA puts cell and gene therapy chief on administrative leave
The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Cheetah Mobile posted a quarterly loss of 11 cents per share, versus a year-ago loss of 32 cents per share. The company's ...
Exosome Research Market is expected to generate a revenue of USD 646.52 Million by 2032, Globally, at 13.93% CAGR: Verified Market Research®
The Exosome Research Market presents strong growth opportunities fueled by rising demand for non-invasive diagnostics, ...